ADHD Trial, Recruiting NCT07136636 Sponsor: Semmelweis University Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT07136636
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child must have been born between 2017 and 2023 with moderate to severe lack of oxygen to the brain around the time of birth (HIE), and received cooling treatment at Semmelweis University Children's Hospital
  • The child must have been born at 35 weeks of pregnancy or later (not very premature)
  • The child must have attended follow-up check-ups at around two years of age
  • A parent or guardian must be willing to give written permission for the child to take part

Who may not be able to join:

  • The child has hearing loss
  • The child is growing up in a home where more than one language is spoken regularly
  • The child was born with physical or structural abnormalities present from birth
  • The child has a metabolic disease (a condition affecting how the body processes energy or certain substances)
  • The child experienced a sudden unexpected collapse after birth (confirm with trial site)
  • The child has a brain injury that was caused by something other than lack of oxygen at birth
  • The child has severe difficulties with physical movement, shown by a low score on a standard developmental test taken at two years of age (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Semmelweis University
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇭🇺 Hungary

Primary endpoints

Cognitive abilities - WPPSI-IV; Language abilities - KOBAK

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov